Trial intelligence / Profile preview

Ciclosporine vs Extracorporal Photopheresis in Severe Atopic Dermatitis

NCT02226068Completed

Sponsor
Aarhus University
Start
Jun 2002
Primary completion
Aug 2003
Modality
Peptides, Small Molecules
01

Overview

Randomised trial of cyclosporine in atopic dermatitis (AD) (2 arms), sponsored by Aarhus University. Primary endpoint: SCORing Atopic Dermatitis at 4 months. Started Jun 2002; status: completed.

02

Drugs

cyclosporine
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT02226068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02226068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call